Reimagining (bio)medicalization, pharmaceuticals and genetics : old critiques and new engagements
Author(s)
Bibliographic Information
Reimagining (bio)medicalization, pharmaceuticals and genetics : old critiques and new engagements
Routledge, 2015
- : hbk
- : pbk
Available at 5 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
In recent years medicalization, the process of making something medical, has gained considerable ground and a position in everyday discourse. In this multidisciplinary collection of original essays, the authors expertly consider how issues around medicalization have developed, ways in which it is changing, and the potential shapes it will take in the future. They develop a unique argument that medicalization, biomedicalization, pharmaceuticalization and geneticization are related and co-evolving processes, present throughout the globe. This is an ideal addition to anthropology, sociology and STS courses about medicine and health.
Table of Contents
Preface: Peter Conrad, Brandeis University Introduction: Susan E. Bell (Bowdoin College) and Anne E. Figert (Loyola University Chicago) "(Bio)Medicalization, Technoscience and Health in a Transnational Perspective: Outlining Old Critiques and New Engagements" PART I: Reimaginings: (Bio)Medicalization and Technoscience in the 21st Century 1. Susan E. Bell (Bowdoin College) and Anne E. Figert (Loyola University Chicago), "Moving Sideways and Forging Ahead: Re-imagining -Izations in the 21st Century" 2. Ellen Annandale (University of York) and Anne Hammarstroem, "A New Biopolitics of Gender and Health? 'Gender-specific medicine' and Pharmaceuticalization" 3. Janet K. Shim, Katherine Weatherford Darling, Sara L. Ackerman, Sandra Soo-Jin Lee, Robert A. Hiatt, (University of California, San Francisco) "Reimagining Race and Ancestry: Biomedicalizing Difference in Post-Genomic Subjects" 4. Commentary and Reflections: Rebecca Herzig (Bates College) "On Stratification and Complexity: Matters of Difference in the Age of Biomedicaliztion" PART II: Pharmaceuticals 5. Jeremy Greene (Johns Hopkins University) "Vital Objects: Essential Drugs and their Critical Legacies" 6. Ari Samsky (Washington University St. Louis) "The Drug Swallowers: Scientific Sovereignty and Pharmaceuticalization in two International Drug Donation Programs" 7. Courtney Cuthbertson, (University of Illinois) "Pharmaceutical Technologies and the Management of Biological Citizens in Chile" 8. Matthew Archibald, (Colby College) "Essential Medicines, Drug Swallowers, and Biological Citizens: The Ongoing Construction of Pharmaceutical Regimes" PART III: Genetics/Genomics 9. Catherine Bliss (University of California, San Francisco) "Biomedicalization and the New Science of Race" 10. Ruha Benjamin (Princeton University) "Racial Destiny or Dexterity? The Global Circulation of Genomics as an Empowerment Idiom" 11. Sara Shostak (Brandeis University) and Margot Moinester (Harvard University) "Beyond Geneticization: Regimes of Perceptibility and the Social Determinants of Health" 12. Commentary and Reflections: David Hecht (Bowdoin College) "The Lure of the Gene" Epilogue: Susan Reverby (Wellesley College) "Mapping the Bio-medicalized World for Justice"
by "Nielsen BookData"